Adar1 Capital Management, LLC Nurix Therapeutics, Inc. Transaction History
Adar1 Capital Management, LLC
- $441 Billion
- Q1 2024
A detailed history of Adar1 Capital Management, LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 35,608 shares of NRIX stock, worth $674,059. This represents 0.12% of its overall portfolio holdings.
Number of Shares
35,608Holding current value
$674,059% of portfolio
0.12%Shares
1 transactions
Others Institutions Holding NRIX
# of Institutions
144Shares Held
50.3MCall Options Held
30.3KPut Options Held
22.7K-
Black Rock Inc. New York, NY4.58MShares$86.7 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.48MShares$84.9 Million2.6% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$73.5 Million0.72% of portfolio
-
Deep Track Capital, LP Greenwich, CT3MShares$56.7 Million1.46% of portfolio
-
State Street Corp Boston, MA2.73MShares$51.7 Million0.0% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $893M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...